Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lixisenatide

Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain

Sanofi · Not applicable · Completed · Enrollment 30

NCT02745470

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Lixisenatide injectionn/rn/rn/rn/r
Normal salinen/rn/rn/rn/r

Not shown

  • Lixisenatide injection: endpoint not reported
  • Normal saline: endpoint not reported